Trials / Terminated
TerminatedNCT02634424
PK Driven Prophylaxis for Hemophilia A
Interest of Preventive Personalized Treatment in Hemophilia A
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- Male
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the implementation of pharmacokinetic (PK) driven prophylaxis in current clinical practice
Detailed description
Starting from 3 pharmacokinetic (PK) points, data are entered in the PK calculator device, and treatment dose is adjusted following the results of PK values obtained and clinical bleeding data
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MyPKFiT | Adjustment of the treatment dose using a decision support software according to the PK values |
Timeline
- Start date
- 2015-11-25
- Primary completion
- 2016-05-12
- Completion
- 2016-05-12
- First posted
- 2015-12-18
- Last updated
- 2020-03-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02634424. Inclusion in this directory is not an endorsement.